The MED1 Protein in DNA Damage Response and Repair

DNA 损伤反应和修复中的 MED1 蛋白

基本信息

  • 批准号:
    7179292
  • 负责人:
  • 金额:
    $ 35.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-07-01 至 2009-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Maintenance of genetic stability relies not only on faithful repair of endogenous and exogenous DNA damage, but also on the prompt activation of checkpoints leading to cell cycle arrest and apoptosis, when damage exceeds a critical threshold. Spontaneous deamination of cytosine and 5-methylcytosine to uracil and thymine at CpG sites is a major mechanism of endogenous mutagenesis and plays an important role in tumorigenesis. Several uracil and thymine DNA N-glycosylases active on G: U and G: T mismatches are present in mammalian cells and protect from deamination events at CpG sites. We identified one of these enzymes, human MED1 (also known as MBD4), as an interact or of the mismatch repair (MMR) protein MLH1. Inactivation MED1 in the mouse germ line increases mutagenicity at CpG sites, but only 3-fold, raising the possibility of compensation by back-up repair activities. One such candidate is the enzyme TDG that has in vitro biochemical activities similar to MED1. Furthermore, the general MMR system may, at least in principle, act on G: T and G: U mismatches. At the moment, the relative contributions of MED1, TDG and MMR to the repair of G: U and G: T mismatches at CpG sites in vivo are unclear. Recently, we identified a novel role of MED1 in the DNA damage response to alkylating agents and other anti-tumor drugs. MED1-/- MEFs treated with increasing doses of alkylating agents, like MNNG, and other anti-tumor drugs, failed to undergo cell cycle arrest and apoptosis. Much like MMR-defective cells, resistance of MED1-/- MEFs to MNNG was due to a tolerance mechanism, as DNA damage accumulated but did not elicit a G2-M checkpoint and p53 activation. MMR proteins levels are markedly reduced in MED1-/- MEFs, suggesting that MED1 may be required for alkylating agent cytotoxicity by maintaining integrity of the MMR signaling complex. We hypothesize that MED1 has a dual role in DNA repair and DNA damage response. Experiments in this proposal are designed to: 1) characterize the role of MED1 in G2-M cell cycle arrest and apoptosis induced by DNA damage; 2) examine the role of MED1 in maintaining integrity of MMR protein levels; 3) examine the roles of MED1, TDG, and MMR in the repair of G: T mismatches at CpG sites in vivo. These studies will provide new insights into mechanisms of endogenous mutagenesis, response to DNA damage and resistance of cancer cells to anti-tumor chemotherapy.
描述(由申请人提供):遗传稳定性的维持不仅依赖于内源性和外源性DNA损伤的忠实修复,而且当损伤超过临界阈值时,还依赖于导致细胞周期停滞和凋亡的检查点的迅速激活。胞嘧啶和5-甲基胞嘧啶在CpG位点自发脱氨为尿嘧啶和胸腺嘧啶是内源性突变的主要机制,在肿瘤发生中起重要作用。哺乳动物细胞中存在一些在G: U和G: T错配上活跃的尿嘧啶和胸腺嘧啶DNA n -糖基酶,并保护它们免受CpG位点的脱胺事件的影响。我们确定了其中一种酶,人类MED1(也称为MBD4),作为错配修复(MMR)蛋白MLH1的相互作用或。小鼠生殖系中MED1的失活增加了CpG位点的突变性,但仅增加了3倍,增加了通过备份修复活动进行补偿的可能性。其中一种候选酶是TDG,它具有与MED1相似的体外生化活性。此外,至少在原则上,一般MMR系统可能对G: T和G: U不匹配起作用。目前,MED1、TDG和MMR对体内CpG位点G: U和G: T错配修复的相对贡献尚不清楚。最近,我们发现MED1在烷基化剂和其他抗肿瘤药物对DNA损伤反应中的新作用。增加烷基化剂(如MNNG)和其他抗肿瘤药物剂量后,MED1-/- MEFs不能发生细胞周期阻滞和凋亡。与mmr缺陷细胞非常相似,MED1-/- mef对MNNG的抗性是由于耐受机制,因为DNA损伤累积但不会引发G2-M检查点和p53激活。在MED1-/- mef中,MMR蛋白水平显著降低,这表明MED1可能需要通过维持MMR信号复合物的完整性来实现烷基化剂的细胞毒性。我们假设MED1在DNA修复和DNA损伤反应中具有双重作用。本实验旨在:1)研究MED1在DNA损伤诱导的G2-M细胞周期阻滞和凋亡中的作用;2)研究MED1在维持MMR蛋白水平完整性中的作用;3)研究MED1、TDG和MMR在体内CpG位点G: T错配修复中的作用。这些研究将为肿瘤细胞的内源性突变机制、DNA损伤反应和抗肿瘤化疗耐药性提供新的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALFONSO BELLACOSA其他文献

ALFONSO BELLACOSA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALFONSO BELLACOSA', 18)}}的其他基金

Identification of first-in-class epigenetic inhibitors that target Thymine DNA Glycosylase (TDG) for future precision therapy of metastatic melanoma
鉴定针对胸腺嘧啶 DNA 糖基化酶 (TDG) 的一流表观遗传抑制剂,用于未来转移性黑色素瘤的精准治疗
  • 批准号:
    10310527
  • 财政年份:
    2020
  • 资助金额:
    $ 35.74万
  • 项目类别:
TDG as a novel target to enhance gemcitabine killing of pancreatic cancer cells
TDG作为增强吉西他滨杀伤胰腺癌细胞的新靶点
  • 批准号:
    8959007
  • 财政年份:
    2015
  • 资助金额:
    $ 35.74万
  • 项目类别:
MED1 MUTATIONS IN COLORECTAL CANCER
结直肠癌中的 MED1 突变
  • 批准号:
    6498066
  • 财政年份:
    2001
  • 资助金额:
    $ 35.74万
  • 项目类别:
MED1 MUTATIONS IN COLORECTAL CANCER
结直肠癌中的 MED1 突变
  • 批准号:
    6225329
  • 财政年份:
    2001
  • 资助金额:
    $ 35.74万
  • 项目类别:
NEW HUMAN DNA REPAIR ENDONUCLEASE
新人类 DNA 修复核酸内切酶
  • 批准号:
    6318462
  • 财政年份:
    1998
  • 资助金额:
    $ 35.74万
  • 项目类别:
NEW HUMAN DNA REPAIR ENDONUCLEASE
新人类 DNA 修复核酸内切酶
  • 批准号:
    6173814
  • 财政年份:
    1998
  • 资助金额:
    $ 35.74万
  • 项目类别:
Regulation of Genomic and Epigenomic Stability at CpG Sites
CpG 位点基因组和表观基因组稳定性的调控
  • 批准号:
    8449521
  • 财政年份:
    1998
  • 资助金额:
    $ 35.74万
  • 项目类别:
NEW HUMAN DNA REPAIR ENDONUCLEASE
新人类 DNA 修复核酸内切酶
  • 批准号:
    2673245
  • 财政年份:
    1998
  • 资助金额:
    $ 35.74万
  • 项目类别:
NEW HUMAN DNA REPAIR ENDONUCLEASE
新人类 DNA 修复核酸内切酶
  • 批准号:
    6376826
  • 财政年份:
    1998
  • 资助金额:
    $ 35.74万
  • 项目类别:
NEW HUMAN DNA REPAIR ENDONUCLEASE
新人类 DNA 修复核酸内切酶
  • 批准号:
    6513273
  • 财政年份:
    1998
  • 资助金额:
    $ 35.74万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 35.74万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 35.74万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.74万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.74万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.74万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 35.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 35.74万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 35.74万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 35.74万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 35.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了